EUVIMEDEUVIMED entdecken
Crossref

Strengthening Japan’s drug discovery and medical research ecosystem: AMED’s innovation challenge

Hitoshi Nakagama

The Journal of Biochemistry · 18.10.2026

DOI: 10.1093/jb/mvag078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Biochemistry, online erschienen am 18.10.2026. Verfasst von Hitoshi Nakagama. Beteiligte Einrichtung: Japan Agency for Medical Research and Development (AMED) Yomiuri Shimbun Bldg. 1-7-1 Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Japan continues to face challenges in translating life science and medical research into innovative medicines and healthcare technologies. The Japan Agency for Medical Research and Development (AMED), established in 2015, plays a central role in bridging basic research and practical application. To address gaps between research and development stages and to promote practical application of promising technological seeds from academia, AMED adopted five strategic priorities under its Third Mid- to Long-Term Plan (2025–29): (i) strengthen coordination across AMED programs to ensure seamless support from basic research to societal implementation, (ii) promote academia-industry collaboration and technology transfer even at early stages of development, including through the AMED IND ENGINE initiative, (iii) support creative, high-impact basic research and further strengthen innovative research by integration of cutting-edge technologies; (iv) advance international research collaboration, multi-regional clinical trials and support for start-ups, with the AMED Global Hub (Boston) serving as a gateway connecting the Japanese drug discovery ecosystem with global partners and (v) accelerate digital transformation by leveraging artificial intelligence, quantum technologies and robust research databases. Taking this integrated approach, AMED aims to revitalize Japan’s drug discovery ecosystem, nurture globally competitive talent and build a world-leading innovation ecosystem that translates scientific excellence into tangible benefits for patients and society.

Schlagwörter

Stichwörter der Autor:innen

AMEDAND-EEcosystemInnovationResearch and Development

Autor:innen und Institutionen

  • Japan Agency for Medical Research and Development (AMED) Yomiuri Shimbun Bldg. 1-7-1 Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan.

Zitieren

APA

Nakagama, H. (2026). Strengthening Japan’s drug discovery and medical research ecosystem: AMED’s innovation challenge. The Journal of Biochemistry. https://doi.org/10.1093/jb/mvag078

Vancouver

Nakagama H. Strengthening Japan’s drug discovery and medical research ecosystem: AMED’s innovation challenge. The Journal of Biochemistry. 2026. doi:10.1093/jb/mvag078

BibTeX
@article{Nakagama2026,
  author = {Nakagama, Hitoshi},
  title = {Strengthening Japan’s drug discovery and medical research ecosystem: AMED’s innovation challenge},
  journal = {The Journal of Biochemistry},
  year = {2026},
  doi = {10.1093/jb/mvag078}
}
Kostenlos starten →